Home blood pressure monitoring with pharmacist support for women

The Effect of Pharmacist-Initiated Home Blood Pressure Monitoring on Blood Pressure Control in Women

Not applicable Interventional University of Alberta · NCT05991414

This study tests if women with high blood pressure can better control their condition by using home monitoring along with support from pharmacists compared to regular care.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment368 (estimated)
Ages18 Years and up
SexFemale
SponsorUniversity of Alberta Academic / other
Locations26 sites (Aylmer, Ontario and 25 other locations)
Trial IDNCT05991414 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of home blood pressure monitoring combined with pharmacist care in improving blood pressure control among women with elevated blood pressure. Participants will be randomized into two groups: one receiving enhanced pharmacist support and home monitoring, and the other receiving usual care. Over a 24-week period, patients will measure their blood pressure at home and share the results with their pharmacists, who will provide tailored education and therapy recommendations. The study aims to determine if this approach leads to better blood pressure management compared to standard care.

Who should consider this trial

Good fit: Ideal candidates are women aged 18 and older with elevated blood pressure or those currently diagnosed with hypertension.

Not a fit: Patients experiencing hypertensive emergencies or those currently using a home blood pressure monitor may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure control in women, leading to better health outcomes.

How similar studies have performed: Previous studies have shown that both home blood pressure monitoring and pharmacist-led care can improve blood pressure management, suggesting a positive outlook for this combined approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients will be included if they are female ≥18 years of age and meet one of the following criteria:

No established diagnosis and/or treatment for hypertension.

* Average of three AOBP readings at two pharmacy visits within a 2-week period:
* SBP ≥140 mmHg or DBP ≥90 mmHg
* SBP ≥130 mmHg or DBP ≥80 mmHg if they have diabetes

Established diagnosis or currently on treatment for hypertension.

* Average of three AOBP readings from one pharmacy visit:
* SBP ≥140mmHg or DBP ≥90mmHg
* SBP ≥130mmHg or DBP ≥80mmHg if they have diabetes

Exclusion Criteria:

* Male
* Having hypertensive urgency or emergency as determined on screening defined as (these patients will be referred to urgent care):
* Severe elevation of SBP \>180mmHg and/or DBP \>120mmHg
* Taking oral contraceptives
* Arm that \<24cm (9.4") or an arm that is \>43cm (17")
* Currently have, or are using a home blood pressure monitor
* No access to a smartphone or internet
* Unwilling or unable to participate or provide informed consent and sign the consent form
* If the patient is pregnant
* Participating or planning to participate in another research study or project

Where this trial is running

Aylmer, Ontario and 25 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hypertension
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.